Financing Cash Flow
Medtronic Financing Cash Flow decreased by 428.4% to -$2.09B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.1%, from -$1.75B to -$2.09B. Over 3 years (FY 2022 to FY 2025), Financing Cash Flow shows an upward trend with a -6.5% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
cf_net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.06B | -$1.16B | -$1.18B | -$1.95B | -$950.00M | $3.01B | -$2.13B | -$4.89B | -$501.00M | -$90.00M | -$1.50B | -$2.36B | -$731.00M | -$534.00M | -$1.75B | -$1.34B | -$1.38B | -$395.00M | -$2.09B |
| QoQ Change | — | -9.5% | -1.9% | -65.6% | +51.3% | +417.3% | -170.8% | -129.1% | +89.8% | +82.0% | <-999% | -57.3% | +69.0% | +26.9% | -228.3% | +23.4% | -2.8% | +71.4% | -428.4% |
| YoY Change | — | — | — | — | +10.0% | +361.0% | -81.3% | -150.9% | +47.3% | -103.0% | +29.7% | +51.8% | -45.9% | -493.3% | -16.9% | +43.1% | -88.9% | +26.0% | -19.1% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Medtronic's financing cash flow?
- Medtronic (MDT) reported financing cash flow of -$2.09B in Q4 2025.
- How has Medtronic's financing cash flow changed year-over-year?
- Medtronic's financing cash flow decreased by 19.1% year-over-year, from -$1.75B to -$2.09B.
- What is the long-term trend for Medtronic's financing cash flow?
- Over 3 years (2022 to 2025), Medtronic's financing cash flow has grown at a -6.5% compound annual growth rate (CAGR), from -$5.34B to -$4.36B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.